Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.

The global Cancer Hormone Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cancer Hormone Therapy Drugs in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cancer Hormone Therapy Drugs include Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Hormone Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Hormone Therapy Drugs.

Report Scope

The Cancer Hormone Therapy Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Hormone Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Hormone Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Hormone Therapy Drugs Market Report

Report Metric	Details
Report Name	Cancer Hormone Therapy Drugs Market
Segment by Type	Tamoxifen Aromatase Inhibitors Antiandrogens Androgen Synthesis Inhibitors Other
Segment by Application	Breast Cancer Prostate Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca, Novartis, Aspen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Hormone Therapy Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Hormone Therapy Drugs Market report?

Ans: The main players in the Cancer Hormone Therapy Drugs Market are Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca, Novartis, Aspen

What are the Application segmentation covered in the Cancer Hormone Therapy Drugs Market report?

Ans: The Applications covered in the Cancer Hormone Therapy Drugs Market report are Breast Cancer, Prostate Cancer

What are the Type segmentation covered in the Cancer Hormone Therapy Drugs Market report?

Ans: The Types covered in the Cancer Hormone Therapy Drugs Market report are Tamoxifen, Aromatase Inhibitors, Antiandrogens, Androgen Synthesis Inhibitors, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Tamoxifen

1.2.3 Aromatase Inhibitors

1.2.4 Antiandrogens

1.2.5 Androgen Synthesis Inhibitors

1.2.6 Other

1.3 Market by Application

1.3.1 Global Cancer Hormone Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Hormone Therapy Drugs Market Perspective (2019-2030)

2.2 Cancer Hormone Therapy Drugs Growth Trends by Region

2.2.1 Global Cancer Hormone Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Hormone Therapy Drugs Historic Market Size by Region (2019-2024)

2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030)

2.3 Cancer Hormone Therapy Drugs Market Dynamics

2.3.1 Cancer Hormone Therapy Drugs Industry Trends

2.3.2 Cancer Hormone Therapy Drugs Market Drivers

2.3.3 Cancer Hormone Therapy Drugs Market Challenges

2.3.4 Cancer Hormone Therapy Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue

3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2019-2024)

3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue

3.4 Global Cancer Hormone Therapy Drugs Market Concentration Ratio

3.4.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2023

3.5 Cancer Hormone Therapy Drugs Key Players Head office and Area Served

3.6 Key Players Cancer Hormone Therapy Drugs Product Solution and Service

3.7 Date of Enter into Cancer Hormone Therapy Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Hormone Therapy Drugs Breakdown Data by Type

4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2019-2024)

4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030)

5 Cancer Hormone Therapy Drugs Breakdown Data by Application

5.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2019-2024)

5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Hormone Therapy Drugs Market Size (2019-2030)

6.2 North America Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)

6.4 North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Hormone Therapy Drugs Market Size (2019-2030)

7.2 Europe Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)

7.4 Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size (2019-2030)

8.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Hormone Therapy Drugs Market Size (2019-2030)

9.2 Latin America Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)

9.4 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size (2019-2030)

10.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Cancer Hormone Therapy Drugs Introduction

11.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Detail

11.2.2 Amgen Business Overview

11.2.3 Amgen Cancer Hormone Therapy Drugs Introduction

11.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.2.5 Amgen Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction

11.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.3.5 Pfizer Recent Development

11.4 Teva

11.4.1 Teva Company Detail

11.4.2 Teva Business Overview

11.4.3 Teva Cancer Hormone Therapy Drugs Introduction

11.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.4.5 Teva Recent Development

11.5 Takeda

11.5.1 Takeda Company Detail

11.5.2 Takeda Business Overview

11.5.3 Takeda Cancer Hormone Therapy Drugs Introduction

11.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.5.5 Takeda Recent Development

11.6 Samyang Biopharmaceuticals

11.6.1 Samyang Biopharmaceuticals Company Detail

11.6.2 Samyang Biopharmaceuticals Business Overview

11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction

11.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.6.5 Samyang Biopharmaceuticals Recent Development

11.7 Tolmar

11.7.1 Tolmar Company Detail

11.7.2 Tolmar Business Overview

11.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction

11.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.7.5 Tolmar Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction

11.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.8.5 AstraZeneca Recent Development

11.9 Novartis

11.9.1 Novartis Company Detail

11.9.2 Novartis Business Overview

11.9.3 Novartis Cancer Hormone Therapy Drugs Introduction

11.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.9.5 Novartis Recent Development

11.10 Aspen

11.10.1 Aspen Company Detail

11.10.2 Aspen Business Overview

11.10.3 Aspen Cancer Hormone Therapy Drugs Introduction

11.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)

11.10.5 Aspen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Samyang Biopharmaceuticals

List of Tables

Table 1. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Tamoxifen

Table 3. Key Players of Aromatase Inhibitors

Table 4. Key Players of Antiandrogens

Table 5. Key Players of Androgen Synthesis Inhibitors

Table 6. Key Players of Other

Table 7. Global Cancer Hormone Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Cancer Hormone Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Cancer Hormone Therapy Drugs Market Share by Region (2019-2024)

Table 11. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Cancer Hormone Therapy Drugs Market Share by Region (2025-2030)

Table 13. Cancer Hormone Therapy Drugs Market Trends

Table 14. Cancer Hormone Therapy Drugs Market Drivers

Table 15. Cancer Hormone Therapy Drugs Market Challenges

Table 16. Cancer Hormone Therapy Drugs Market Restraints

Table 17. Global Cancer Hormone Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Cancer Hormone Therapy Drugs Market Share by Players (2019-2024)

Table 19. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)

Table 20. Ranking of Global Top Cancer Hormone Therapy Drugs Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Cancer Hormone Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Cancer Hormone Therapy Drugs Product Solution and Service

Table 24. Date of Enter into Cancer Hormone Therapy Drugs Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2019-2024)

Table 28. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2025-2030)

Table 30. Global Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2019-2024)

Table 32. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2025-2030)

Table 34. North America Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Cancer Hormone Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. Roche Company Detail

Table 50. Roche Business Overview

Table 51. Roche Cancer Hormone Therapy Drugs Product

Table 52. Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 53. Roche Recent Development

Table 54. Amgen Company Detail

Table 55. Amgen Business Overview

Table 56. Amgen Cancer Hormone Therapy Drugs Product

Table 57. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 58. Amgen Recent Development

Table 59. Pfizer Company Detail

Table 60. Pfizer Business Overview

Table 61. Pfizer Cancer Hormone Therapy Drugs Product

Table 62. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 63. Pfizer Recent Development

Table 64. Teva Company Detail

Table 65. Teva Business Overview

Table 66. Teva Cancer Hormone Therapy Drugs Product

Table 67. Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 68. Teva Recent Development

Table 69. Takeda Company Detail

Table 70. Takeda Business Overview

Table 71. Takeda Cancer Hormone Therapy Drugs Product

Table 72. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 73. Takeda Recent Development

Table 74. Samyang Biopharmaceuticals Company Detail

Table 75. Samyang Biopharmaceuticals Business Overview

Table 76. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product

Table 77. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 78. Samyang Biopharmaceuticals Recent Development

Table 79. Tolmar Company Detail

Table 80. Tolmar Business Overview

Table 81. Tolmar Cancer Hormone Therapy Drugs Product

Table 82. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 83. Tolmar Recent Development

Table 84. AstraZeneca Company Detail

Table 85. AstraZeneca Business Overview

Table 86. AstraZeneca Cancer Hormone Therapy Drugs Product

Table 87. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 88. AstraZeneca Recent Development

Table 89. Novartis Company Detail

Table 90. Novartis Business Overview

Table 91. Novartis Cancer Hormone Therapy Drugs Product

Table 92. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 93. Novartis Recent Development

Table 94. Aspen Company Detail

Table 95. Aspen Business Overview

Table 96. Aspen Cancer Hormone Therapy Drugs Product

Table 97. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)

Table 98. Aspen Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Hormone Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cancer Hormone Therapy Drugs Market Share by Type: 2023 VS 2030

Figure 3. Tamoxifen Features

Figure 4. Aromatase Inhibitors Features

Figure 5. Antiandrogens Features

Figure 6. Androgen Synthesis Inhibitors Features

Figure 7. Other Features

Figure 8. Global Cancer Hormone Therapy Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Cancer Hormone Therapy Drugs Market Share by Application: 2023 VS 2030

Figure 10. Breast Cancer Case Studies

Figure 11. Prostate Cancer Case Studies

Figure 12. Cancer Hormone Therapy Drugs Report Years Considered

Figure 13. Global Cancer Hormone Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Cancer Hormone Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Cancer Hormone Therapy Drugs Market Share by Players in 2023

Figure 17. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2023

Figure 19. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)

Figure 21. United States Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)

Figure 25. Germany Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Cancer Hormone Therapy Drugs Market Share by Region (2019-2030)

Figure 33. China Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)

Figure 41. Mexico Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)

Figure 45. Turkey Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 48. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 49. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 50. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 51. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 52. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 53. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 54. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 55. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 56. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions